Items where authors include "Kotsianidis, Ioannis"

Article

Garelius, Hege Kristin Gravdahl, Bagguley, Timothy orcid.org/0000-0002-6150-3467, Taylor, Adele orcid.org/0000-0001-7793-8222 et al. (20 more authors) (2025) Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents:an observational cohort study. The Lancet Haematology. e128-e137. ISSN 2352-3026

Tasis, Athanasios, Papaioannou, Nikos E, Grigoriou, Maria et al. (19 more authors) (2024) Single-cell analysis of bone marrow CD8+ T cells in Myeloid Neoplasms reveals pathways associated with disease progression and response to treatment with Azacitidine. Cancer research communications. ISSN 2767-9764

Garelius, H K G, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Bagguley, Timothy Charles orcid.org/0000-0002-6150-3467 et al. (20 more authors) (2022) Erythropoietin stimulation agents significantly improves outcome in lower risk MDS. HemaSphere. S168. pp. 69-70. ISSN 2572-9241

Oster, Howard S., Crouch, Simon orcid.org/0000-0002-3026-2859, Smith, Alexandra orcid.org/0000-0002-1111-966X et al. (26 more authors) (2021) A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS. Blood Advances. pp. 3066-3075. ISSN 2473-9537

Bernard, Elsa, Nannya, Yasuhito, Hasserjian, Robert P. et al. (76 more authors) (2020) Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nature Medicine. 1549–1556. ISSN 1546-170X

de Witte, Theo, Malcovati, Luca, Fenaux, Pierre et al. (26 more authors) (2020) Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective. Haematologica. pp. 2516-2523.